US Stock MarketDetailed Quotes

Contineum Therapeutics (CTNM)

Watchlist
  • 13.630
  • -0.580-4.08%
Trading May 15 10:42 ET
509.58MMarket Cap-7.03P/E (TTM)

Contineum Therapeutics (CTNM) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-12.86%-16.27M
-68.40%-55.31M
-27.84%-13.04M
-97.71%-12.2M
-84.27%-15.66M
-80.71%-14.41M
-269.75%-32.85M
4.69%-10.2M
-14.73%-6.17M
-120.90%-8.5M
Net income from continuing operations
9.59%-14.46M
-41.93%-59.98M
-4.06%-15.16M
-24.59%-12.79M
-78.04%-16.04M
-89.97%-15.99M
-285.99%-42.26M
-87.48%-14.57M
-64.25%-10.27M
-121.68%-9.01M
Operating gains losses
-96.92%2K
-35.29%55K
-500.00%-6K
--0
---4K
-44.44%65K
507.14%85K
87.50%-1K
----
----
Depreciation and amortization
6.41%83K
25.19%323K
13.33%85K
30.65%81K
31.67%79K
27.87%78K
32.31%258K
102.70%75K
44.19%62K
42.86%60K
Other non cash items
167.81%624K
23.85%1.08M
152.94%387K
87.90%233K
-35.33%227K
-4.51%233K
141.52%872K
-42.26%153K
-47.01%124K
112.26%351K
Change In working capital
-449.63%-5.95M
-213.22%-6.04M
-124.78%-731K
-198.88%-2.29M
-825.36%-1.93M
-493.45%-1.08M
620.90%5.33M
205.73%2.95M
107.15%2.32M
-112.58%-209K
-Change in prepaid assets
-896.06%-1.62M
-482.86%-3.4M
-535.53%-2.5M
-367.82%-1.17M
-47.37%70K
-71.53%203K
169.46%887K
-1,541.67%-394K
135.11%435K
189.13%133K
-Change in payables and accrued expense
-195.23%-3.04M
-140.21%-1.39M
-31.88%2.26M
-146.55%-870K
-35.24%-1.75M
-128.44%-1.03M
116.06%3.44M
248.70%3.32M
-30.26%1.87M
-170.16%-1.29M
-Change in other current assets
----
-99.68%3K
--9K
--0
----
----
13,285.71%937K
--0
101.67%1K
3,127.59%936K
-Change in other current liabilities
-404.28%-1.3M
-2,010.61%-1.26M
-1,867.86%-495K
-2,076.92%-257K
-2,038.46%-252K
-2,241.67%-257K
104.90%66K
104.92%28K
104.96%13K
105.12%13K
Cash from discontinued investing activities
Operating cash flow
-12.86%-16.27M
-68.40%-55.31M
-27.84%-13.04M
-97.71%-12.2M
-84.27%-15.66M
-80.71%-14.41M
-269.75%-32.85M
4.69%-10.2M
-14.73%-6.17M
-120.90%-8.5M
Investing cash flow
Cash flow from continuing investing activities
-363.55%-39.31M
94.68%-3.71M
-405.46%-47.45M
149.50%14.94M
135.69%13.88M
70.83%14.92M
-6.36%-69.74M
-203.96%-9.39M
23.58%-30.18M
12.50%-38.9M
Net PPE purchase and sale
-563.83%-312K
53.24%-231K
74.70%-42K
-58.06%-98K
63.03%-44K
68.03%-47K
-19.32%-494K
46.28%-166K
-181.82%-62K
-283.87%-119K
Net investment purchase and sale
-360.63%-39M
94.97%-3.48M
-414.11%-47.41M
149.93%15.04M
135.92%13.93M
68.53%14.96M
-6.28%-69.25M
-198.75%-9.22M
23.69%-30.12M
12.71%-38.78M
Cash from discontinued investing activities
Investing cash flow
-363.55%-39.31M
94.68%-3.71M
-405.46%-47.45M
149.50%14.94M
135.69%13.88M
70.83%14.92M
-6.36%-69.74M
-203.96%-9.39M
23.58%-30.18M
12.50%-38.9M
Financing cash flow
Cash flow from continuing financing activities
437.50%129K
3.38%112.69M
14,458.41%93.47M
146,861.54%19.11M
-99.92%91K
233.33%24K
94.03%109M
300.00%642K
-99.87%13K
131.60%108.36M
Net issuance payments of debt
----
----
----
----
----
----
--0
--0
--0
--0
Net common stock issuance
----
3.74%112.26M
--93.24M
--19.01M
----
----
386,567.86%108.21M
--0
--0
----
Net preferred stock issuance
----
----
----
----
----
----
--0
--0
--0
----
Proceeds from stock option exercised by employees
725.00%198K
-13.16%686K
-65.42%222K
1,230.77%173K
1,953.85%267K
-80.33%24K
396.86%790K
1,184.00%642K
-84.15%13K
-31.58%13K
Net other financing activities
---69K
---256K
--0
---80K
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
437.50%129K
3.38%112.69M
14,458.41%93.47M
146,861.54%19.11M
-99.92%91K
233.33%24K
94.03%109M
300.00%642K
-99.87%13K
131.60%108.36M
Net cash flow
Beginning cash position
244.54%75.6M
41.33%21.94M
4.26%42.63M
-73.09%20.78M
38.16%22.47M
41.33%21.94M
178.79%15.53M
133.38%40.89M
48.32%77.23M
79.45%16.26M
Current changes in cash
-10,620.87%-55.45M
736.22%53.66M
274.00%32.97M
160.13%21.85M
-102.77%-1.69M
-28.59%527K
-35.55%6.42M
-849.77%-18.95M
-5.18%-36.34M
41.76%60.97M
End cash Position
-10.29%20.16M
244.54%75.6M
244.54%75.6M
4.26%42.63M
-73.09%20.78M
38.16%22.47M
41.33%21.94M
41.33%21.94M
133.38%40.89M
48.32%77.23M
Free cash flow
-14.66%-16.58M
-66.50%-55.54M
-26.20%-13.08M
-96.69%-12.3M
-82.23%-15.71M
-78.02%-14.46M
-276.18%-33.36M
5.86%-10.37M
-15.78%-6.25M
-121.20%-8.62M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -12.86%-16.27M-68.40%-55.31M-27.84%-13.04M-97.71%-12.2M-84.27%-15.66M-80.71%-14.41M-269.75%-32.85M4.69%-10.2M-14.73%-6.17M-120.90%-8.5M
Net income from continuing operations 9.59%-14.46M-41.93%-59.98M-4.06%-15.16M-24.59%-12.79M-78.04%-16.04M-89.97%-15.99M-285.99%-42.26M-87.48%-14.57M-64.25%-10.27M-121.68%-9.01M
Operating gains losses -96.92%2K-35.29%55K-500.00%-6K--0---4K-44.44%65K507.14%85K87.50%-1K--------
Depreciation and amortization 6.41%83K25.19%323K13.33%85K30.65%81K31.67%79K27.87%78K32.31%258K102.70%75K44.19%62K42.86%60K
Other non cash items 167.81%624K23.85%1.08M152.94%387K87.90%233K-35.33%227K-4.51%233K141.52%872K-42.26%153K-47.01%124K112.26%351K
Change In working capital -449.63%-5.95M-213.22%-6.04M-124.78%-731K-198.88%-2.29M-825.36%-1.93M-493.45%-1.08M620.90%5.33M205.73%2.95M107.15%2.32M-112.58%-209K
-Change in prepaid assets -896.06%-1.62M-482.86%-3.4M-535.53%-2.5M-367.82%-1.17M-47.37%70K-71.53%203K169.46%887K-1,541.67%-394K135.11%435K189.13%133K
-Change in payables and accrued expense -195.23%-3.04M-140.21%-1.39M-31.88%2.26M-146.55%-870K-35.24%-1.75M-128.44%-1.03M116.06%3.44M248.70%3.32M-30.26%1.87M-170.16%-1.29M
-Change in other current assets -----99.68%3K--9K--0--------13,285.71%937K--0101.67%1K3,127.59%936K
-Change in other current liabilities -404.28%-1.3M-2,010.61%-1.26M-1,867.86%-495K-2,076.92%-257K-2,038.46%-252K-2,241.67%-257K104.90%66K104.92%28K104.96%13K105.12%13K
Cash from discontinued investing activities
Operating cash flow -12.86%-16.27M-68.40%-55.31M-27.84%-13.04M-97.71%-12.2M-84.27%-15.66M-80.71%-14.41M-269.75%-32.85M4.69%-10.2M-14.73%-6.17M-120.90%-8.5M
Investing cash flow
Cash flow from continuing investing activities -363.55%-39.31M94.68%-3.71M-405.46%-47.45M149.50%14.94M135.69%13.88M70.83%14.92M-6.36%-69.74M-203.96%-9.39M23.58%-30.18M12.50%-38.9M
Net PPE purchase and sale -563.83%-312K53.24%-231K74.70%-42K-58.06%-98K63.03%-44K68.03%-47K-19.32%-494K46.28%-166K-181.82%-62K-283.87%-119K
Net investment purchase and sale -360.63%-39M94.97%-3.48M-414.11%-47.41M149.93%15.04M135.92%13.93M68.53%14.96M-6.28%-69.25M-198.75%-9.22M23.69%-30.12M12.71%-38.78M
Cash from discontinued investing activities
Investing cash flow -363.55%-39.31M94.68%-3.71M-405.46%-47.45M149.50%14.94M135.69%13.88M70.83%14.92M-6.36%-69.74M-203.96%-9.39M23.58%-30.18M12.50%-38.9M
Financing cash flow
Cash flow from continuing financing activities 437.50%129K3.38%112.69M14,458.41%93.47M146,861.54%19.11M-99.92%91K233.33%24K94.03%109M300.00%642K-99.87%13K131.60%108.36M
Net issuance payments of debt --------------------------0--0--0--0
Net common stock issuance ----3.74%112.26M--93.24M--19.01M--------386,567.86%108.21M--0--0----
Net preferred stock issuance --------------------------0--0--0----
Proceeds from stock option exercised by employees 725.00%198K-13.16%686K-65.42%222K1,230.77%173K1,953.85%267K-80.33%24K396.86%790K1,184.00%642K-84.15%13K-31.58%13K
Net other financing activities ---69K---256K--0---80K------------------------
Cash from discontinued financing activities
Financing cash flow 437.50%129K3.38%112.69M14,458.41%93.47M146,861.54%19.11M-99.92%91K233.33%24K94.03%109M300.00%642K-99.87%13K131.60%108.36M
Net cash flow
Beginning cash position 244.54%75.6M41.33%21.94M4.26%42.63M-73.09%20.78M38.16%22.47M41.33%21.94M178.79%15.53M133.38%40.89M48.32%77.23M79.45%16.26M
Current changes in cash -10,620.87%-55.45M736.22%53.66M274.00%32.97M160.13%21.85M-102.77%-1.69M-28.59%527K-35.55%6.42M-849.77%-18.95M-5.18%-36.34M41.76%60.97M
End cash Position -10.29%20.16M244.54%75.6M244.54%75.6M4.26%42.63M-73.09%20.78M38.16%22.47M41.33%21.94M41.33%21.94M133.38%40.89M48.32%77.23M
Free cash flow -14.66%-16.58M-66.50%-55.54M-26.20%-13.08M-96.69%-12.3M-82.23%-15.71M-78.02%-14.46M-276.18%-33.36M5.86%-10.37M-15.78%-6.25M-121.20%-8.62M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More